Preparation method and application of lactobacillus paracasei LP-Liang culture

CN119020232APending Publication Date: 2024-11-26HUAZHONG AGRI UNIV

Patent Information

Application Number
CN202411436037.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-10-15
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

对于副干酪乳杆菌的生长而言,一方面,受溶氧含量、生长温度、pH、接种量等培养条件以及培养基的碳源、氮源等组成成分的影响;另一方面,副干酪乳杆菌在生长代谢过程中产生的乳酸等代谢产物的积累会使其所处环境的pH急剧下降从而严重抑制自身的生长

Benefits of technology

[0020] By using the Lactobacillus paracasei LP-Liang culture to conduct in vivo experiments on mice, the present invention confirms that the culture of Lactobacillus paracasei LP-Liang screened and prepared by the present invention can safely and effectively alleviate the symptoms caused by the intestinal tract of mice. Weight loss caused by inflammation, inhibition of diarrhea and hematochezia in model mice, inhibition of colon shortening and up-regulation of intestinal flora diversity, achieving the effect of preventing and treating inflammatory bowel disease, proving that the paracheese milk prepared by the present invention Bacillus LP-Liang culture has broad application prospects in the prevention and treatment of inflammatory bowel disease.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119020232A_ABST
    Figure CN119020232A_ABST
Patent Text Reader

Abstract

The invention discloses a preparation method and application of a lactobacillus paracasei LP-Liang culture, and belongs to the technical field of microorganisms. The lactobacillus paracasei LP-Liang is preserved in the China Center for Type Culture Collection, the preservation number is CCTCC NO: M 20241648, and the preservation address is Wuhan University, Wuhan, China. The lactobacillus paracasei LP-Liang culture is used for mouse in-vivo experiments, and it is proved that the lactobacillus paracasei culture obtained through screening can safely and effectively relieve the condition of weight loss caused by mouse intestinal inflammation, inhibit diarrhea and hematochezia of model mice, inhibit colon shortening and up-regulate the diversity of intestinal flora, and the lactobacillus paracasei LP-Liang culture has the advantages of being capable of effectively relieving the condition of weight loss caused by mouse intestinal inflammation, and capable of improving the immunity of the mice. The effect of preventing and treating the inflammatory bowel disease is achieved. It is proved that the lactobacillus paracasei LP-Liang culture prepared through the method has a wide application prospect in prevention and treatment of inflammatory bowel diseases.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of microorganisms, and in particular relates to a preparation method of a Lactobacillus paracasei LP-Liang culture and application thereof. Background Art

[0002] Lactobacillus paracasei (L.paracasei) belongs to the genus Lactobacillus, is a facultative anaerobic bacterium, the width of the bacterium is 2.0-4.0 μm, the length is 0.8-1.0 μm, has strong adaptability, can survive in most environments, such as dairy products, plant products, oral cavity and intestinal environment. Lactobacillus paracasei is widely used as a starter and auxiliary starter for dairy products such as milk, yogurt, soy milk, cream and cheese. Lactobacillus paracasei has good acid resistance and bile resistance, can reduce plasma cholesterol, enhance the host's nonspecific resistance to microbial pathogens, accelerate the removal of pathogens in the intestine, can treat intestinal flora disorders and alleviate the increase in intestinal permeability, thereby preventing food allergies and acute diarrhea.

[0003] With the development of science and technology, people have a deeper understanding of probiotics. Lactobacillus paracasei has a very broad development and application prospect due to its significant functional characteristics. It is currently found that Lactobacillus paracasei from different sources exhibits different probiotic properties, and with the continuous understanding of the characteristics of the strain, it can be better put into a wider range of practical applications. For the growth of Lactobacillus paracasei, on the one hand, it is affected by culture conditions such as dissolved oxygen content, growth temperature, pH, inoculation amount, and components such as carbon source and nitrogen source of the culture medium; on the other hand, the accumulation of metabolites such as lactic acid produced by Lactobacillus paracasei during the growth and metabolism process will cause the pH of its environment to drop sharply, thereby seriously inhibiting its own growth. Therefore, the premise of obtaining large quantities, high density, and high activity of Lactobacillus paracasei for industrial application is to find a suitable proliferation culture medium for the bacteria. And only by screening strains that can relieve mouse ulcerative colitis can it have a good promotion and application value. Summary of the invention

[0004] In order to solve the above technical problems, the present invention provides a preparation method of Lactobacillus paracasei LP-Liang culture and its application. The Lactobacillus paracasei LP-Liang culture prepared by the present invention can safely and effectively alleviate the weight loss caused by intestinal inflammation in mice, inhibit diarrhea and blood in stool in model mice, inhibit the shortening of the colon and increase the diversity of intestinal flora, thereby achieving the effect of preventing and treating inflammatory bowel disease.

[0005] Technical solution 1: A strain of Lactobacillus paracasei LP-Liang (Lactobacillus paracasei LP-Liang), which has been deposited in China Center for Type Culture Collection, with a deposit number of CCTCCNO: M20241648 and a deposit address of Wuhan University, Wuhan, China.

[0006] Technical solution 2: A method for preparing a Lactobacillus paracasei LP-Liang culture, comprising the step of inoculating the growth seed liquid of the Lactobacillus paracasei LP-Liang into a fermentation medium for cultivation.

[0007] Furthermore, the components of the fermentation medium include: 10-12 g oats, 6-9 g rice flour, 4-7 g calcium carbonate, 0.1-0.8 g yeast extract powder, 0.04-0.32 g soy peptone, 3×10 3 -9×10 3 U, saccharifying enzyme 2.0×10 7 -3.0×10 7 U, magnesium sulfate 0.3-0.6 g, lysine 0.01-0.03 g and water 40-45 mL.

[0008] Furthermore, the inoculation amount is 0.64×10 8 -3.2×10 8 CFU / g.

[0009] Technical solution three: The total viable count of the Lactobacillus paracasei LP-Liang culture prepared according to the preparation method is ≥4.56×10 10 CFU / g.

[0010] Technical solution 4: Use of the Lactobacillus paracasei LP-Liang or the Lactobacillus paracasei LP-Liang culture in the preparation of products for preventing and / or treating inflammatory bowel disease.

[0011] Furthermore, the product prevents and / or treats the inflammatory bowel disease through one or more of the following pathways:

[0012] (1) Reduce weight loss;

[0013] (2) Suppress diarrhea and blood in stool;

[0014] (3) inhibiting the increase of spleen index;

[0015] (4) Increase colon length.

[0016] Furthermore, the inflammatory bowel disease includes ulcerative colitis and Crohn's disease.

[0017] Furthermore, the product includes medicines and additives.

[0018] Furthermore, the total number of viable bacteria in the active ingredients of the product is ≥ 4.5×10 10 CFU / g.

[0019] Compared with the prior art, the present invention has the following advantages and technical effects:

[0020] The present invention uses the Lactobacillus paracasei LP-Liang culture to conduct an in vivo experiment on mice, confirming that the Lactobacillus paracasei LP-Liang screened and prepared by the present invention can safely and effectively alleviate the weight loss caused by intestinal inflammation in mice, inhibit diarrhea and bloody stools in model mice, inhibit the shortening of the colon and increase the diversity of intestinal flora, thereby achieving the effect of preventing and treating inflammatory bowel disease, and proving that the Lactobacillus paracasei LP-Liang culture prepared by the present invention has broad application prospects in the prevention and treatment of inflammatory bowel disease. BRIEF DESCRIPTION OF THE DRAWINGS

[0021] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.

[0022] Figure 1 The effect of different culture conditions on the bacterial count of the culture;

[0023] Figure 2 The effect of different carbon sources on the bacterial count of the culture;

[0024] Figure 3 The effect of different nitrogen sources on the bacterial count of the culture;

[0025] Figure 4 The effects of different combinations of inorganic salt ions and growth-promoting factors on the bacterial count in the culture;

[0026] Figure 5 is the weight change of mice in each group;

[0027] Figure 6 The changes in DAI scores of mice in each group;

[0028] Figure 7 The changes of spleen index of mice in each group;

[0029] Figure 8The changes of colon length in each group of mice. DETAILED DESCRIPTION

[0030] Various exemplary embodiments of the present invention will now be described in detail. This detailed description should not be considered as limiting the present invention, but should be understood as a more detailed description of certain aspects, features, and embodiments of the present invention.

[0031] It should be understood that the terms described in the present invention are only for describing special embodiments and are not intended to limit the present invention. In addition, for the numerical range in the present invention, it should be understood that each intermediate value between the upper and lower limits of the scope is also specifically disclosed. Each smaller range between the intermediate value in any stated value or stated range and any other stated value or intermediate value in the described range is also included in the present invention. The upper and lower limits of these smaller ranges can be independently included or excluded in the scope.

[0032] Unless otherwise indicated, all technical and scientific terms used herein have the same meanings as those generally understood by those skilled in the art. Although the present invention describes only preferred methods and materials, any methods and materials similar or equivalent to those described herein may also be used in the implementation or testing of the present invention. All documents mentioned in this specification are incorporated by reference to disclose and describe the methods and / or materials associated with the documents. In the event of a conflict with any incorporated document, the content of this specification shall prevail.

[0033] It will be apparent to those skilled in the art that various modifications and variations may be made to the specific embodiments of the present invention description without departing from the scope or spirit of the present invention. Other embodiments derived from the present invention description will be apparent to those skilled in the art. The present invention description and examples are exemplary only.

[0034] The words “include,” “including,” “have,” “contain,” etc. used in this document are open-ended terms, meaning including but not limited to.

[0035] Unless otherwise specified, the reagents and materials used in the examples can be obtained through conventional purchase.

[0036] Example 1

[0037] 1. Experimental Methods

[0038] 1.1 Culture medium configuration

[0039] MRS medium: 10g protein Chen, 5g beef powder, 4g yeast powder, 2g glucose, 1ml Tween 80, 2g potassium dihydrogen phosphate, 5g sodium acetate, 2g ammonium citrate, 0.2g magnesium sulfate, 0.05g manganese sulfate, 15g agar powder, 1000ml distilled water. pH value 6.8-7.0. Solid medium is based on liquid medium with 2% agar powder added, and all medium are sterilized at 115℃ for 25min.

[0040] 1.2 Isolation and screening of strains

[0041] Collect an appropriate amount of sample from the feces of healthy infants (usually without gastrointestinal symptoms and without taking drugs that affect intestinal flora before sampling). The sample size is generally determined according to the experimental needs, but it should be ensured to be sufficient for subsequent operations. The collected fecal sample is quickly transferred to a sterile container, and an appropriate amount of sterile saline or buffer is added for dilution and mixing to reduce impurities and microbial concentration differences in the sample. The pretreated fecal suspension is gradient diluted to obtain bacterial solutions of different concentrations. This helps to isolate single colonies in subsequent cultures. Select a suitable dilution (such as 10-4, 10-5, etc.) and evenly spread the bacterial solution on the MRS culture medium. Multiple parallel plates can be set for each dilution to increase the reliability of screening. Place the coated plate in a constant temperature biochemical incubator and culture anaerobically at 37°C for 48 hours.

[0042] 1.3 Isolation and purification of strains

[0043] After the cultivation is completed, the colony morphology on the plate is observed to select the suspected Lactobacillus paracasei colony. The colony characteristics of Lactobacillus paracasei include white or yellowish color, sticky texture, round and neatly edged morphology, 1-2 mm diameter and Gram-positive staining, etc. The picked colony is inoculated onto a new MRS culture medium plate by a three-zone line method or a four-zone line method for further purification. Repeat this step until a pure culture is obtained.

[0044] 1.4 Identification and verification of strains

[0045] The DNA of the pure culture was extracted, and PCR amplification was performed using specific primers of Lactobacillus paracasei, and the amplified product was detected by gel electrophoresis. At the same time, 16S rRNA gene sequencing was performed, and the sequencing results were compared with the sequences of known strains to determine that it was Lactobacillus paracasei. It was named Lactobacillus paracasei LP-Liang (Lactobacillus paracasei LP-Liang), and has been preserved in the China Center for Type Culture Collection, with a preservation number of: CCTCC NO: M 20241648, and the preservation address is: Wuhan University, Wuhan, China.

[0046] 2. Screening of culture conditions

[0047] 2.1 Preparation of seed solution

[0048] The Lactobacillus paracasei LP-Liang preserved in a -80°C glycerol tube was inoculated into a triangular flask (MRS medium), and cultured in a bacterial incubator at 37°C for 15 hours for later use.

[0049] 2.2 Screening of culture medium conditions

[0050] 2.2.1 Place Lactobacillus paracasei LP-Liang in a culture medium for cultivation; the culture medium components include: 10 g oats, 9 g rice flour, 4 g calcium carbonate, 0.2 g yeast extract powder, 0.08 g soy peptone and 40 mL water, natural pH; the culture conditions of the culture medium are set to conditions 1 to 9 respectively:

[0051] Condition 1: temperature 35°C, feed-water ratio 1:1.2, loading height 2.6 cm, inoculum size 0.64×10 8 CFU / g;

[0052] Condition 2: temperature 37°C, feed-water ratio 1:1.2, loading height 2.6 cm, inoculum size 0.64×10 8 CFU / g;

[0053] Condition 3: temperature 39°C, feed-water ratio 1:1.2, loading height 2.6 cm, inoculum size 0.64×10 8 CFU / g;

[0054] Condition 4: temperature 37°C, feed-water ratio 1:1.4, loading height 2.6 cm, inoculum size 0.64×10 8 CFU / g;

[0055] Condition 5: temperature 37°C, feed-water ratio 1:1.6, loading height 2.6 cm, inoculum size 0.64×10 8 CFU / g;

[0056] Condition 6: temperature 37°C, feed-water ratio 1:1.4, loading height 7.8 cm, inoculum size 0.64×10 8 CFU / g;

[0057] Condition 7: temperature 37°C, feed-water ratio 1:1.4, loading height 13 cm, inoculum size 0.64×10 8 CFU / g;

[0058] Condition 8: temperature 37°C, feed-water ratio 1:1.4, loading height 13 cm, inoculum size 1.92×10 8 CFU / g;

[0059] Condition 9: temperature 37°C, feed-water ratio 1:1.4, loading height 13 cm, inoculum size 3.2×10 8 CFU / g.

[0060] 2.2.2 Viable bacteria count

[0061] The fermentation was carried out according to the schemes in conditions 1 to 9, and the obtained fermentation product was diluted with water and then the viable bacteria were counted according to the dilution plate method. Figure 1 As shown. Figure 1 It can be seen that under different culture conditions, the number of bacteria obtained by fermentation is different. Among them, the content of live bacteria in the fermentation product of the Lactobacillus paracasei LP-Liang screened by the present invention was the highest when condition 8 was used to culture the Lactobacillus paracasei LP-Liang, which was 1.82×10 10 CFU / g, and this condition was subsequently selected as the culture condition for Lactobacillus paracasei LP-Liang.

[0062] 2.3 Screening of medium carbon source and medium pretreatment conditions

[0063] 2.3.1 Seed solution preparation as in 2.1. Fermentation medium configuration and culture conditions: 10 g oats, 9 g rice flour, 4 g calcium carbonate, 0.2 g yeast extract, carbon source, 0.08 g soy peptone and 40 mL water, natural pH; feed-water ratio 1:1.4, loading height 13 cm, inoculum size 1.92 × 10 8 CFU / g, constant temperature of 37°C, solid-state fermentation culture for 48h; the carbon source in the fermentation medium and the medium pretreatment conditions were set to condition 1-condition 7 respectively.

[0064] Condition 1: medium pretreatment conditions 121℃, 20min, high temperature α-amylase addition amount 3×10 3 U, the amount of saccharifying enzyme added was 2×10 7 U;

[0065] Condition 2: medium pretreatment conditions 115℃, 30min, high temperature α-amylase addition amount 3×10 3 U, the amount of saccharifying enzyme added was 2×10 7 U;

[0066] Condition 3: medium pretreatment conditions 100℃, 30min, high temperature α-amylase addition 3×10 3 U, the amount of saccharifying enzyme added was 2×10 7 U;

[0067] Condition 4: medium pretreatment conditions 100℃, 30min, high temperature α-amylase addition amount 6×10 3 U, the amount of saccharifying enzyme added was 2×107 U;

[0068] Condition 5: medium pretreatment conditions 100℃, 30min, high temperature α-amylase addition amount 9×10 3 U, the amount of saccharifying enzyme added was 2×10 7 U;

[0069] Condition 6: medium pretreatment conditions 100℃, 30min, high temperature α-amylase addition amount 9×10 3 U, the amount of saccharifying enzyme added was 2.5×10 7 U;

[0070] Condition 7: medium pretreatment conditions 100℃, 30min, high temperature α-amylase addition amount 9×10 3 U, the amount of saccharifying enzyme added was 3×10 7 U; respectively, the carbon source was optimized and cultured according to the above conditions.

[0071] 2.3.2 Live bacteria count

[0072] The fermentation product prepared according to conditions 1-7 was diluted with water and viable bacteria were counted according to the dilution plate method. The number of fermented bacteria was as follows: Figure 2 As shown in the figure, different carbon source culture conditions have different fermentation bacteria numbers. The strain cultured under carbon source culture condition 6 has the highest content of live bacteria in the fermentation product, which is 2.82×10 10 CFU / g, and this carbon source culture condition was selected for subsequent cultivation.

[0073] 2.4 Nitrogen source concentration screening

[0074] 2.4.1 Seed solution preparation as in 2.1. Fermentation medium configuration and culture conditions: 10 g oats, 9 g rice flour, 4 g calcium carbonate, yeast extract powder, soy peptone and 40 mL water, natural pH; feed-water ratio 1:1.4, loading height 13 cm, inoculum size 1.92 × 10 8 CFU / g, medium pretreatment conditions 100℃, 30min, high temperature α-amylase addition amount 9×10 3 U, the amount of saccharifying enzyme added was 2.5×10 7 U, constant temperature of 37°C, solid-state fermentation culture for 48 hours; the nitrogen source concentration in the fermentation medium was set to the following medium 1-medium 4:

[0075] Medium 1: 0.1 g yeast extract powder, 0.04 g soy peptone;

[0076] Medium 2: 0.2 g yeast extract powder, 0.08 g soy peptone;

[0077] Medium 3: 0.4 g yeast extract powder, 0.16 g soy peptone;

[0078] Culture medium 4: 0.8 g yeast extract powder, 0.32 g soy peptone.

[0079] 2.4.2 Viable bacteria count

[0080] The fermentation product obtained by fermentation under the conditions of medium 1-4 was diluted with water and the viable bacteria were counted according to the dilution plate method. The number of fermented bacteria was as follows: Figure 3 As shown in the figure, different nitrogen source concentrations have different fermentation bacteria numbers. When the nitrogen source concentration is 0.4g yeast extract powder and 0.16g soy peptone, the content of live bacteria in the fermentation product is the highest, which is 3.05×10 10 CFU / g, and this nitrogen source concentration culture condition was selected for subsequent cultivation.

[0081] 2.5. Screening of different inorganic salt ions and growth-promoting factors

[0082] 2.5.1 See 2.1 for the preparation of seed solution. Fermentation medium: 10 g oats, 9 g rice flour, 4 g calcium carbonate, 0.4 g yeast extract powder, inorganic salt ions and growth factors, 0.16 g soy peptone and 40 mL water; natural pH, feed-water ratio 1:1.4, loading height 13 cm, inoculum size 1.92 × 10 8 CFU / g, fermentation medium pretreatment conditions 100℃, 30min, high temperature α-amylase addition amount 9×10 3 U, the amount of saccharifying enzyme added was 2.5×10 7 U, constant temperature of 37°C, solid-state fermentation culture for 48 hours; the inorganic salt ions and growth-promoting factors in the fermentation medium are set to fermentation medium A-fermentation medium L respectively:

[0083] Fermentation medium A: magnesium sulfate 0.3 g;

[0084] Fermentation medium B: magnesium sulfate 0.6 g;

[0085] Fermentation medium C: ferrous sulfate 0.15 g;

[0086] Fermentation medium D: ferrous sulfate 0.3 g;

[0087] Fermentation medium E: lysine 0.01 g;

[0088] Fermentation medium F: lysine 0.03 g;

[0089] Fermentation medium G: tyrosine 0.01 g;

[0090] Fermentation medium H: tyrosine 0.03 g;

[0091] Fermentation medium I: magnesium sulfate 0.6 g, ferrous sulfate 0.3 g;

[0092] Fermentation medium J: magnesium sulfate 0.6 g, lysine 0.03 g;

[0093] Fermentation medium K: magnesium sulfate 0.6 g, tyrosine 0.03 g;

[0094] Fermentation medium L: magnesium sulfate 0.6 g, lysine 0.03 g, tyrosine 0.03 g.

[0095] 2.5.2 Viable bacteria count

[0096] The fermentation product obtained by fermentation under the conditions of medium AL was diluted with water and the viable bacteria were counted according to the dilution plate method. The number of fermented bacteria was as follows: Figure 4 As shown in the figure, the fermentation medium J was used to ferment Lactobacillus paracasei LP-Liang. The types and combinations of inorganic salt ions and growth-promoting factors in the medium had the best fermentation effect, and the number of viable bacteria could reach up to 4.56×10 10 CFU / g, which can fully meet the needs of practical applications.

[0097] 3. Effect of Lactobacillus paracasei LP-Liang culture in treating experimental colitis in mice

[0098] 3.1 The Lactobacillus paracasei LP-Liang stored in a -80°C glycerol tube was inoculated into a triangular flask (MRS medium) and cultured in a bacterial incubator at 37°C for 15 h to obtain a seed culture solution; the seed culture solution was inoculated into a fermentation medium (sterilized at 100°C for 30 min) with an inoculum size of 1.92×10 8 CFU / g, feed-water ratio 1:1.4, loading height 13 cm, temperature 37 ° C, culture for 48 h to obtain Lactobacillus paracasei LP-Liang culture. The components of the fermentation medium include: 10 g oats, 9 g rice flour, 4 g calcium carbonate, 0.4 g yeast extract powder, 0.6 g magnesium sulfate, 0.03 g lysine, 0.16 g soy peptone, 40 mL water, 9 × 10 high temperature α-amylase 3 U and saccharifying enzyme 2.5×10 7 U, natural pH.

[0099] 3.2 Experimental animal models and groups:

[0100] 60 healthy male C57 mice weighing 20±2g were purchased from the Experimental Animal Center of Huazhong Agricultural University and kept in an SPF animal room. They were randomly divided into 4 groups, 15 mice in each group, and all mice were adaptively fed for 7 days before the experiment. The four groups were normal group (NC), model group (MC), culture group (PYW), and inactivated culture group (SPYW). The experimental design was as follows:

[0101] (1) Normal group: free diet and drinking water, intragastric administration of 0.2 mL of normal saline every day, and body weight, stool characteristics and bleeding degree were recorded;

[0102] (2) Model group: free diet and free drinking of 3% dextran sulfate sodium (DSS) for 7 days, followed by normal drinking water for the next 7 days, and oral administration of 0.2 mL of normal saline every day, and body weight, stool characteristics, and bleeding degree were recorded;

[0103] (3) Culture group: free diet and free drinking of 3% DSS for 7 days, followed by normal drinking water for the next 7 days, daily gavage of Lactobacillus paracasei LP-Liang solid culture (1 mg / g bw), and body weight, stool characteristics, and bleeding degree were recorded;

[0104] (4) Inactivated culture group: The mice were allowed to eat and drink 3% DSS freely for 7 days, and then replaced with normal drinking water for recovery after 7 days. The mice were gavaged with inactivated Lactobacillus paracasei LP-Liang solid culture (1 mg / gb.w.) every day, and the body weight, stool characteristics and bleeding degree were recorded.

[0105] Mouse weight changes:

[0106] After oral gavage, the mice were weighed at a fixed time every day. The results showed that:

[0107] (1) The weight of mice in the normal group gradually increased during the 14 days of the experiment;

[0108] (2) All mice in the DSS group experienced weight loss;

[0109] (3) All intervention groups experienced weight loss, but the rate of weight change in the Lactobacillus paracasei LP-Liang culture group was the lowest.

[0110] The above results show that supplementing the Lactobacillus paracasei LP-Liang culture of the present invention can effectively alleviate the symptoms of DSS-induced weight loss (see Figure 5 ).

[0111] 3.3 Calculation of Disease Activity Integral (DAI) in Mice:

[0112] After the oral administration, the weight, stool characteristics and occult blood of the mice were observed daily, and the disease score activity (DAI score) of each mouse was calculated to evaluate the degree of colitis activity. The results are as follows:

[0113] (1) The DAI scores of mice in the normal group remained stable at zero level;

[0114] (2) The DAI scores of mice in both the gavage culture and inactivated culture groups gradually increased;

[0115] (3) During the experimental period, the DAI of mice in the culture group was significantly lower than that in the model group.

[0116] The above results show that supplementing the Lactobacillus paracasei LP-Liang culture of the present invention can effectively alleviate the diarrhea and bloody stool caused by intestinal inflammation in mice (see Figure 6 ).

[0117] 3.4 Calculation of mouse spleen index:

[0118] On the 14th day after gavage, the mice were killed by cervical dislocation, and the spleen of the mice was taken out and its weight was measured. The ratio of the spleen weight to the body weight of the mice was the spleen index. The results showed that:

[0119] (1) After the experiment, the spleen index of mice in the model group was significantly higher than that in the normal group;

[0120] (2) Compared with the model group, the spleen index of mice gavaged with Lactobacillus paracasei LP-Liang culture was significantly decreased.

[0121] The above results show that supplementing the Lactobacillus paracasei LP-Liang culture of the present invention can effectively alleviate the DSS-induced systemic inflammatory response (see Figure 7 ).

[0122] 3.5 On the 14th day after oral administration, the mice were killed by cervical dislocation, and the colon was removed and measured. The results showed that:

[0123] (1) After the experiment, the colon length of mice in the model group was significantly shorter than that in the normal group;

[0124] (2) Compared with the model group, the colon length of mice gavaged with Lactobacillus paracasei LP-Liang culture increased significantly.

[0125] The above results show that supplementing the Lactobacillus paracasei LP-Liang culture of the present invention can effectively alleviate the shortening of the colon caused by DSS (see Figure 8 ).

[0126] The embodiments described above are only descriptions of the preferred modes of the present invention, and are not intended to limit the scope of the present invention. Without departing from the design spirit of the present invention, various modifications and improvements made to the technical solutions of the present invention by ordinary technicians in this field should all fall within the protection scope determined by the claims of the present invention.

Claims

1. A strain of Lactobacillus paracasei LP-Liang (Lactobacillus paracasei LP-Liang), characterized in that: The Lactobacillus paracasei LP-Liang has been deposited in China Center for Type Culture Collection with a deposit number of CCTCC NO: M20241648 and a deposit address of Wuhan University, Wuhan, China.

2. A method for preparing a Lactobacillus paracasei LP-Liang culture, characterized in that: The method comprises the step of inoculating the growth seed liquid of Lactobacillus paracasei LP-Liang described in claim 1 into a fermentation medium for culturing.

3. The preparation method according to claim 2, characterized in that: The components of the fermentation medium include: 10-12 g of oats, 6-9 g of rice flour, 4-7 g of calcium carbonate, 0.1-0.8 g of yeast extract powder, 0.04-0.32 g of soy peptone, 3×10 3 -9×10 3 U, saccharifying enzyme 2.0×10 7 -3.0×10 7 U, magnesium sulfate 0.3-0.6 g, lysine 0.01-0.03 g and water 40-45 mL.

4. The preparation method according to claim 2, characterized in that: The inoculation volume was 0.64×10 8 -3.2×10 8 CFU / g.

5. The Lactobacillus paracasei LP-Liang culture prepared by the preparation method according to any one of claims 2 to 4, characterized in that: The total viable count of the Lactobacillus paracasei LP-Liang culture is ≥4.56×10 10 CFU / g.

6. Use of the Lactobacillus paracasei LP-Liang according to claim 1 or the Lactobacillus paracasei LP-Liang culture according to claim 5 in preparing a product for preventing and / or treating inflammatory bowel disease.

7. The use according to claim 6, characterized in that: The product prevents and / or treats the inflammatory bowel disease through one or more of the following pathways: (1) Reduce weight loss; (2) Suppress diarrhea and blood in stool; (3) inhibiting the increase of spleen index; (4) Increase colon length.

8. The use according to claim 6, characterized in that: The inflammatory bowel diseases include ulcerative colitis and Crohn's disease.

9. The use according to claim 6, characterized in that: The products include medicines and additives.

10. The use according to claim 6, characterized in that: The total number of viable bacteria in the active ingredients of the product is ≥4.5×10 10 CFU / g.

Citation Information

Patent Citations

  • Lactic acid bacteria composition and application thereof

    CN114672441A

  • Lactobacillus paracasei capable of efficiently expressing adenosine deaminase to relieve colitis

    CN114854638A

  • Composition for relieving ulcerative colitis and application

    CN115501259A

  • Bifidobacterium lactis strain for preventing or treating colitis and use thereof

    US20230069454A1

Cited By

  • Lactobacillus paracasei SX-M1559 and application thereof in preparation of drugs for reducing blood sugar and lipid and resisting inflammation

    CN119709557A